/-/https/www.sciencebuddies.org/cdn/Files/21464/5/sb-logo.png){kind=logo}
/-/https/www.sciencebuddies.org/cdn/Files/21464/5/sb-logo.png){kind=logo}
News Results (top 2,000 results)
|
Select a resource
Filter by
Sort by
|
News Article
April 30, 2012
In a surveillance study of over 12 million bacteria, investigators at the George Washington University and Providence Hospital found E. coli antimicrobial resistance to ciprofloxacin, the most commonly prescribed antimicrobial for urinary tract infections in the US, increased over five-fold from 2000 to 2010.
Read more
News Article
November 18, 2022
Antibiotics won’t work on the COVID virus, but in places like India, their overuse threatens to nullify their effects on other equally deadly pathogens
Read more
News Article
February 8, 2012
A study led by the University of Leicester has found that anti-obesity drugs coupled with lifestyle advice are effective in reducing weight and BMI.
Read more
News Article
May 31, 2012
Despite past safety concerns, the antioxidant supplement beta-carotene, is safe to use during radiation therapy treatments for prostate cancer and does not increase the risk of prostate cancer death or metastases, according to a study in the May issue of the International Journal of Radiation Oncology•Biology•Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).
Read more
News Article
April 10, 2012
Alzheimer's disease (AD) is now the sixth leading cause of death among Americans. There is currently no treatment that alters the course of this disease. However, an increasing amount of evidence suggests that changes in the way the body handles iron and other metals like copper and zinc may start years before the onset of AD symptoms. A new study shows that reducing iron levels in blood plasma may protect the brain from changes related to AD.
Read more
News Article
May 29, 2012
A specific antioxidant supplement may be an effective therapy for some features of autism, according to a pilot trial from the Stanford University School of Medicine and Lucile Packard Children's Hospital that involved 31 children with the disorder.
Read more
News Article
March 25, 2012
Researchers have found that the antiplatelet drug abciximab significantly decreased damage to the heart muscle in patients with ST-segment-elevation myocardial infarction, the most severe type of heart attack. Results of INFUSE-AMI trial were presented today at the ACC's 61st Annual Scientific Session and published simultaneously in the March 25th online issue of the Journal of the American Medical Association. Researchers also found that clot aspiration did not significantly reduce the damage…
Read more
News Article
January 9, 2014
In a prime example of finding new uses for older drugs, studies in zebrafish show that a 50-year-old antipsychotic medication called perphenazine can actively combat the cells of a difficult-to-treat form of acute lymphoblastic leukemia, according to a study published in the Journal of Clinical Investigation. The drug works by turning on a cancer-suppressing enzyme called PP2A and causing malignant tumor cells to self-destruct.
Read more
News Article
April 4, 2012
Low doses of a commonly used atypical antipsychotic drug improved survival in a mouse model of anorexia nervosa, University of Chicago researchers report this month. The result offers promise for a common and occasionally fatal eating disorder that currently lacks approved drugs for treatment.
Read more
News Article
May 24, 2012
An anti-psychotic drug used to treat schizophrenia appears to get rid of cancer stem cells by helping them differentiate into less threatening cell types. The discovery reported in the Cell Press journal Cell on May 24 comes after researchers screened hundreds of compounds in search of those that would selectively inhibit human cancer stem cells, and it may lead rather swiftly to a clinical trial.
Read more
|
/-/https/img.youtube.com/vi/ZbdS3nATiiE/0.jpg)
/-/https/img.youtube.com/vi/iqtQ8Ikq-Ew/0.jpg)
/-/https/img.youtube.com/vi/6KttMKX17YE/0.jpg)